Earnings Preview: Amgen to report 1Q results BusinessWeek Amgen is partnering with British drugmaker AstraZeneca PLC to jointly develop five Amgen antibodies for potential treatments for inflammatory diseases, including asthma, disease of the skin and ulcerative colitis. Amgen will get $50 million, AstraZeneca will pay ... and more » Link To Article
No comments:
Post a Comment